L.K. Benson & Company, P.C. Abb Vie Inc. Transaction History
L.K. Benson & Company, P.C.
- $142 Billion
- Q4 2024
A detailed history of L.K. Benson & Company, P.C. transactions in Abb Vie Inc. stock. As of the latest transaction made, L.K. Benson & Company, P.C. holds 1,952 shares of ABBV stock, worth $374,452. This represents 0.24% of its overall portfolio holdings.
Number of Shares
1,952Holding current value
$374,452% of portfolio
0.24%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,975Shares Held
1.26BCall Options Held
16.4MPut Options Held
12.9M-
Vanguard Group Inc Valley Forge, PA173MShares$33.2 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.2 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$15.2 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$10 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.43 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $339B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...